This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Nature Reviews Cardiology, Published online: 12 February 2025; doi:10.1038/s41569-025-01137-y Differing definitions and questionable prognostic significance have caused confusion and controversy around the applicability of the current definitions of periprocedural and perioperative myocardialinfarction in clinical practice.
Publication date: Available online 21 February 2025 Source: The American Journal of Cardiology Author(s): Sandeep Jha, Aaron Shekka Espinosa, Linnea Molander, Angela Poller, Valentyna Sevastianova, Koen Simons, Julia Baranowska, Thorsteinn Gudmundsson, Emanuele Bobbio, Rickard Zeijlon, Carlo Pirazzi, Andreas Martinsson, Tomas Mellberg, Petronella Torild, (..)
tim.hodson Tue, 03/04/2025 - 10:17 March 3, 2025 Genentech, a member of the Roche Group, recently announced that the U.S. TNKase is also FDA-approved for the treatment of acute ST-elevation myocardialinfarction (STEMI) in adults. For more information, go to [link].
Stroke, Volume 56, Issue Suppl_1 , Page AHUP9-AHUP9, February 1, 2025. Background:Blood pressure (BP) management is crucial for secondary prevention of stroke and myocardialinfarction (MI); however, optimal BP control remains a challenge, particularly among historically disenfranchised populations.
Publication date: Available online 25 March 2025 Source: The American Journal of Cardiology Author(s): Josephine Warren, Luke Dawson, Tori McCollom, Lauren Hudson, Misha Dagan, Adil Zia, Helen Kavnoudias, Philip Lew, James Shaw, Dion Stub, Andrew J Taylor
tim.hodson Mon, 03/31/2025 - 10:26 March 31, 2025 AGEPHA Pharma USA, LLC, has released clinical data that provides new information about how low-dose colchicine, 0.5 mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease.
Publication date: Available online 1 April 2025 Source: The American Journal of Cardiology Author(s): Jayadevan Sreedharan, Anshul Yadav, Neelesh Gupta, Rajeev Gupta
Publication date: Available online 17 March 2025 Source: The American Journal of Cardiology Author(s): Abhishek Chaturvedi, Hector M. Garcia-Garcia, Matteo Cellamare, Parul Chandrika, Waiel Abusnina, Cheng Zhang, Ron Waksman
Stone, MD Mount Sinai Health System tim.hodson Wed, 04/02/2025 - 15:26 March 31, 2025 Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective for patients with severely calcified coronary artery disease than conventional angiography, the more commonly used technique.
Publication date: Available online 6 February 2025 Source: The American Journal of Cardiology Author(s): Francesco Gallo, Ada Cutolo, Antonio Antonucci, Gabriele Cordoni, Elisabetta Demurtas, Andrea Panza, Sakis Themistoclakis
tim.hodson Tue, 01/14/2025 - 10:11 Jan. Users of smokeless tobacco products had increased risk for myocardialinfarction and mortality due to coronary heart disease.
Stroke, Volume 56, Issue 1 , Page 113-121, January 1, 2025. BACKGROUND:Physical activity is an effective modifiable behavior for preventing recurrent strokes. This study aims to determine the adherence to physical activity recommendations among stroke survivors in the United States.
Circulation, Volume 151, Issue 1 , Page 59-75, January 7, 2025. The pathophysiological mechanisms regulating YAP subcellular localization after myocardialinfarction remain poorly defined.METHODS:We identified YAP acetylation at site K265 by in vitro acetylation followed by mass spectrometry analysis.
Journal of the American Heart Association, Volume 14, Issue 5 , March 4, 2025. An increasing number of studies have shown the impact of social determinants of health (SDoHs) on different cardiovascular outcomes. In congenital heart diseases, SDoHs can affect major outcomes, as well.
Circulation: Cardiovascular Interventions, Volume 18, Issue 3 , Page e014899, March 1, 2025. BACKGROUND:Ineligibility for surgical revascularization is increasingly prevalent and associated with increased mortality after percutaneous coronary intervention (PCI).
AHA announced a $12M investment in AI research, with an RFP slated for early 2025. The NUDGE-FLU trial revealed cardiovascular-focused messaging increased flu vaccination rates in myocardialinfarction patients. Get the latest knowledge and practical tools in cardiometabolic health to improve your practice in 2025.
Stroke, Volume 56, Issue Suppl_1 , Page AWP282-AWP282, February 1, 2025. 1.53), P=0.88), myocardialinfarction (OR, 0.97(95%CI: Background:Atrial fibrillation is a common arrhythmia that increases the risk of stroke. 0.75), P<0.001), stroke by 44% (OR, 0.56(95%CI: 0.81), P=0.01) when compared with aspirin.
Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014592, January 1, 2025. BACKGROUND:Food and Drug Administrationmandated postmarket studies for transcatheter aortic valve replacement in low-risk populations plan to use passively collected registry data linked to claims for long-term follow-up out to 10 years.
Stroke, Volume 56, Issue Suppl_1 , Page AWP302-AWP302, February 1, 2025. Introduction:Colchicine, an anti-inflammatory medication, has demonstrated significant benefits in reducing inflammation and decreasing subsequent vascular events in patients with acute coronary syndrome and myocardialinfarction (MI).
Stroke, Volume 56, Issue Suppl_1 , Page AWMP13-AWMP13, February 1, 2025. Although increasing evidence suggests that neurological disorders, such as stroke underlying a brain-heart axis can lead to myocardial injury and cardiac dysfunction, the heart-brain axis remains to be completely understood.To
Stroke, Volume 56, Issue Suppl_1 , Page ATP13-ATP13, February 1, 2025. 1.06), P=0.14) and myocardialinfarction (OR, 1.07(95%CI: Background:Atrial fibrillation (AF) patients carry a high risk of stroke, and treatment related bleeding complications. 0.91), P<0.01), stroke by 19% (OR, 0.81(95%CI:
Stroke, Volume 56, Issue Suppl_1 , Page ADP52-ADP52, February 1, 2025. We further compared our findings with the adherence observed among myocardialinfarction (MI) survivors.Methods:We utilized data from the 2011-2019 Behavioral Risk Factor Surveillance System, a nationally representative survey.
tim.hodson Mon, 03/31/2025 - 10:26 March 31, 2025 AGEPHA Pharma USA, LLC, has highlighted clinical data that provides new information about how low-dose colchicine, 0.5 mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease.
Stroke, Volume 56, Issue Suppl_1 , Page AWP296-AWP296, February 1, 2025. Background:Prior research has identified a strong relationship between individual personality characteristics and prehospital delay in acute myocardialinfarction.
Stroke, Volume 56, Issue Suppl_1 , Page AWP289-AWP289, February 1, 2025. Background:The ABCD-GENE score, incorporating age, body mass index, chronic kidney disease, diabetes, and CYP2C19 genotypes, is a validated risk score that integrates clinical risk factors with genetic information to predict clopidogrel response.
Stroke, Volume 56, Issue Suppl_1 , Page AWP141-AWP141, February 1, 2025. Background:A recent prospective study reported that myocardialinfarction (MI) was present in nearly half of ischemic stroke patients with substantially elevated troponin, with 1 in 5 having a type 1 MI.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP108-AWMP108, February 1, 2025. MACE was defined as a composite of all-cause mortality, myocardialinfarction, and cerebrovascular events. Background:Previous studies have linked pericoronary artery adipose tissue attenuation to major adverse cardiac event (MACE).
Stroke, Volume 56, Issue Suppl_1 , Page ATP82-ATP82, February 1, 2025. Pre-activation benefits have been noted in myocardialinfarction cases, indicating potential advantages for stroke care [3].A The RACE scale evaluates five clinical features: facial palsy, arm/leg paralysis, head/gaze deviation, and aphasia/agnosia.
Stroke, Volume 56, Issue Suppl_1 , Page ATP229-ATP229, February 1, 2025. In conclusion, the most frequent etiology of readmission for elective procedures is cardiac complications, e.g. heart failure and myocardialinfarction, while the most frequent source for nonelective procedures is neurological complications, e.g. CVA/TIA.
Stroke, Volume 56, Issue Suppl_1 , Page AWP317-AWP317, February 1, 2025. The ECG abnormalities investigated included AF, recent ST-elevation myocardialinfarction (STEMI), left ventricular hypertrophy (LVH), right ventricular hypertrophy (RVH), P-pulmonale, and P-mitrale.
Stroke, Volume 56, Issue Suppl_1 , Page ATP98-ATP98, February 1, 2025. Objectives:We evaluate the potential link between post-acute care, particularly care provided at inpatient rehabilitation facilities (IRF) (vs.
Stroke, Volume 56, Issue Suppl_1 , Page ATP328-ATP328, February 1, 2025. Objective:The role of statins in the management of intracerebral hemorrhage (ICH) remains controversial. Model fit was assessed using the Hosmer-Lemeshow test.Results:Among 142 eligible pre-ICH statin users (median age [IQR]: 77.5 [72-86] 72-86] years; 57.0%
Stroke, Volume 56, Issue Suppl_1 , Page ATMP110-ATMP110, February 1, 2025. MNPs are emerging as a potential risk factor for cerebrovascular events such as myocardialinfarction and stroke in recent clinical study. Introduction:Over the past few decades, plastics have been widely used in many products.
Stroke, Volume 56, Issue Suppl_1 , Page ADP39-ADP39, February 1, 2025. The proportions of patients who developed acute myocardialinfarction, respiratory failure, acute kidney injury, or required blood transfusion was higher in patients with atrial fibrillation in both CAS and CEA groups. versus 18.8%
Stroke, Volume 56, Issue Suppl_1 , Page A57-A57, February 1, 2025. Mechanical thrombectomy (MT) has transformed care for patients with small or moderate core infarcts and recently expanded to include those with large infarcts, demonstrating both functional and survival benefits. Other baseline demographics were comparable.
Stroke, Volume 56, Issue Suppl_1 , Page A141-A141, February 1, 2025. Introduction:Randomized clinical trials (RCTs) are the gold standard for evaluating treatment effects, but they are costly, time-consuming, and complex. Therefore, selecting the most promising novel treatments for RCTs is vital.
Stroke, Volume 56, Issue Suppl_1 , Page AWP328-AWP328, February 1, 2025. Adverse vascular outcomes used as endpoints include acute ischemic stroke, acute myocardialinfarction, deep vein thrombosis/pulmonary embolism, AF, and carotid artery dissection.A The first ECG that showed NSR is used as the index ECG.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content